Description
Metavex™ is a prescription folic acid–containing dietary supplement intended to support metabolic health. Each tablet contains a combination of vitamins, minerals, and botanical ingredients formulated to provide nutritional support.
The following Structured Product Label (SPL) was submitted to the FDA by Oncora Pharma, Llc for the product Metavex (NDC 85477-503). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description, indications and usage, contraindications, warnings, precautions, dosage and administration, how supplied, display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Metavex™ is a prescription folic acid–containing dietary supplement intended to support metabolic health. Each tablet contains a combination of vitamins, minerals, and botanical ingredients formulated to provide nutritional support.
Metavex™ is indicated as a prescription dietary supplement for the dietary management of individuals with metabolic health needs where folic acid supplementation is appropriate.
Administration:
Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Metavex™ is contraindicated in patients with known hypersensitivity to any of its components.
Metavex™ should be administered under the supervision of a licensed medical practitioner.
Patients should not exceed the recommended dosage.
If adverse reactions occur, discontinue use and consult a healthcare professional.
Folic Acid and Vitamin B12 Deficiency:
Folic acid administered alone may be inappropriate for the treatment of pernicious anemia or other megaloblastic anemias where vitamin B12 deficiency is present. Doses of folic acid greater than 0.1 mg daily may mask hematologic signs of pernicious anemia while neurological manifestations continue to progress.
Patients with underlying medical conditions or those taking other medications should consult their healthcare provider prior to use.
Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Metavex™ is supplied as tan, oval tablets in bottles of 30 tablets.
NDC 85477-503-30
* Please review the disclaimer below.